Maxion Therapeutics
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- $166M
Investors
- 8
About Maxion Therapeutics
, operates as a biotechnology platform that develops therapeutic drugs for chronic pain, autoimmunity, and cardiovascular disease. In March 2025, Maxion Therapeutics Ltd. The company offers therapies addressing chronic pain, autoimmunity, and cardiovascular diseases via the ion channel and GPCR-driven diseases. The company KnotBody® Technology by fusing naturally occurring cysteine-rich miniproteins (Knottins) into antibody binding loops in ion channel and GPCR drug discovery, offering superior selectivity compared to small-molecule drugs.
Who invested in Maxion Therapeutics
8 investors across 3 rounds
See all investors in Maxion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Maxion Therapeutics
Who invested in Maxion Therapeutics?
Maxion Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Maxion Therapeutics raised?
Maxion Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Maxion Therapeutics last raise money?
Maxion Therapeutics's most recent round on record is a Series A, in Mar 2025.
What does Maxion Therapeutics do?
, operates as a biotechnology platform that develops therapeutic drugs for chronic pain, autoimmunity, and cardiovascular disease.
Where is Maxion Therapeutics headquartered?
Maxion Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like Maxion Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Maxion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Maxion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.